Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis.
about
A functional role for CCR6 on proallergic T cells in the gastrointestinal tractFostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join ForcesShining a light on intestinal trafficThe early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestineSphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel DiseaseTherapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitisS1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancerDietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel diseaseOzanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity."Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression.The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epitheliumSphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fireSphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel diseaseImmunological function of sphingosine 1-phosphate in the intestine.Targeting T-cell migration in inflammatory bowel disease.Nutritional components regulate the gut immune system and its association with intestinal immune disease development.Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.Total alkaloids of Sophora alopecuroides increases the expression of CD4+ CD25+ Tregs and IL-10 in rats with experimental colitis.Perilla frutescens extract ameliorates DSS-induced colitis by suppressing proinflammatory cytokines and inducing anti-inflammatory cytokines.Targeting S1P in Inflammatory bowel disease: new avenues for modulating intestinal leukocyte migration.FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice.
P2860
Q24655787-74F7EEBF-1313-4505-BB7A-D9613C0D0998Q26765948-27D356E1-C4E6-4A81-9BAF-DEFFB039B389Q26863227-300FE2EA-2E43-476D-A1A8-5BC0031F2D63Q27316832-FB6EAA0E-83EC-453D-ADEC-8ECE8E82B10FQ28073700-B1CEB2A4-ECEF-4027-82BA-7EF80B9B6271Q28740568-BAE9BCB1-0FD7-44E1-9A90-464172FC5D33Q33857794-D7B33430-DAF6-472E-A3EA-3C2369EC2A27Q34349248-C673ADF5-3092-4865-9663-6AE21EC390D3Q34518822-AE24CF67-EB57-4E2F-B1BF-0C97DAA9BE1CQ34593159-5C4BF7E9-59C0-40D7-BF0E-EC7CD39A6B99Q35103261-538DD03A-9FEA-4156-B217-7A428771CEF2Q36211058-1C7E8809-9AA0-4F40-95A0-152B1F0A4747Q36229005-9EE318E9-2441-460C-89EE-B4F36C764438Q36708344-741193B9-0EDD-4900-99FD-842FFBF7ADBCQ37317783-D26BA0B3-4EAB-435E-96AF-7CA7DCBB7894Q38016160-65B8F411-D28D-492B-861D-00BCF762861CQ38040430-5FD3CC67-55AB-4EB3-B5F3-2C2C19ADB764Q38164064-1F410C3F-57E6-46AF-9AE8-A8B7F081F67CQ39014759-159074C0-5B7F-477F-AC35-FF6345932B45Q43101781-603BD8CB-8FC3-4EC5-A9BF-2D4DB16755ECQ46819627-F946B818-578A-4902-8522-92AEC977990EQ47725521-74E86B68-D7D4-4E87-BCF7-65179392EF03Q51983634-ED4E470E-4A2A-4D9D-8AC3-10E7AC92348FQ53644116-EBE9C168-84D4-49CC-8360-2A0A44364FB9
P2860
Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@en
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@nl
type
label
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@en
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@nl
prefLabel
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@en
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@nl
P2093
P2860
P1476
Therapeutic effects of a new l ...... e-deficient mice with colitis.
@en
P2093
Daisuke Kishi
Hikaru Matsuda
Hiroshi Kiyono
Hiroshi Tamagawa
Riichiro Nezu
Toshinori Ito
Tsunekazu Mizushima
Yasuyuki Kai
P2860
P304
P356
10.1097/00054725-200405000-00002
P577
2004-05-01T00:00:00Z